EPIC SCIENCES

In News

Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC - Business Wire

Business Wire - Apr 14, 2023

Prostate Cancer: Epic Sciences AR-V7 Test - OncLive

OncLive - Apr 02, 2021

Epic Sciences gathers $52M for blood tests that match cancer patients to therapies - Fierce Biotech

Fierce Biotech - Sep 17, 2018

Epic Sciences Launches New Corporate Branding and Website - PR Newswire

PR Newswire - May 13, 2019

Epic Sciences Raises $24M in Series G - citybiz

citybiz - Apr 17, 2023

PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armstrong - UroToday

UroToday - Apr 21, 2023

Lloyd Sanders Named New CEO of Epic Sciences - Inside Precision Medicine

Inside Precision Medicine - Mar 26, 2019

Peter Kuhn Appointed University Professor - USC Dornsife

USC Dornsife - Mar 01, 2024

From Computer Science to Classics, an Epic Journey - Dartmouth

Dartmouth - Jul 09, 2024

How liquid biopsies are transforming precision cancer care - Nature

Nature - Apr 20, 2021

Slone Partners Recruits Chief Medical Officer for Epic Sciences - Hunt Scanlon Media

Hunt Scanlon Media - May 21, 2019

New Life Sciences Program Will Unify Clinical Research with Care Delivery - Epic Systems

Epic Systems - Sep 19, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment